BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11596040)

  • 21. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
    Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
    Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the estimation of survival.
    Henson DE; Ries LA
    Semin Surg Oncol; 1994; 10(1):2-6. PubMed ID: 8115782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the Clinical Practice Research Datalink.
    Redaniel MT; Martin RM; Ridd MJ; Wade J; Jeffreys M
    PLoS One; 2015; 10(5):e0126608. PubMed ID: 25933397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer mortality surveillance--United States, 1990-2000.
    Stewart SL; King JB; Thompson TD; Friedman C; Wingo PA
    MMWR Surveill Summ; 2004 Jun; 53(3):1-108. PubMed ID: 15179359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of state-specific life tables on relative survival.
    Stroup AM; Cho H; Scoppa SM; Weir HK; Mariotto AB
    J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):218-27. PubMed ID: 25417235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of young age on prostate cancer survival: a population-based assessment (United States).
    Merrill RM; Bird JS
    Cancer Causes Control; 2002 Jun; 13(5):435-43. PubMed ID: 12146848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
    Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
    Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year relative survival from prostate, breast, colorectal and lung cancer.
    Ellison LF; Gibbons L;
    Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy improves survival in rectal small cell cancer - Analysis of Surveillance Epidemiology and End Results (SEER) data.
    Modrek AS; Hsu HC; Leichman CG; Du KL
    Radiat Oncol; 2015 Apr; 10():101. PubMed ID: 25902707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
    Golan T; Urban D; Berger R; Lawrence YR
    Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conditional survival among cancer patients in the United States.
    Merrill RM; Hunter BD
    Oncologist; 2010; 15(8):873-82. PubMed ID: 20647391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional survival of malignant thymoma using national population-based surveillance, epidemiology, and end results (SEER) registry (1973-2011).
    Kim E; Thomas CR
    J Thorac Oncol; 2015 Apr; 10(4):701-7. PubMed ID: 25590603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.
    Smart CR
    Cancer; 1997 Nov; 80(9):1835-44. PubMed ID: 9351557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and overall survival among elderly cancer patients in a tertiary cancer center.
    Antunes YP; Bugano DD; Giglio Ad; Kaliks RA; Karnakis T; Pontes Lde B
    Einstein (Sao Paulo); 2015; 13(4):487-91. PubMed ID: 26676269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
    Hu CY; Xing Y; Cormier JN; Chang GJ
    Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional survival of patients with hepatocellular carcinoma: results from the Surveillance, Epidemiology, and End Results registry.
    Zhang G; Li R; Deng Y; Zhao L
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):515-523. PubMed ID: 29543072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in cancer mortality in 15 industrialized countries, 1969-1986.
    Hoel DG; Davis DL; Miller AB; Sondik EJ; Swerdlow AJ
    J Natl Cancer Inst; 1992 Mar; 84(5):313-20. PubMed ID: 1738181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Men and women show similar survival outcome in stage IV breast cancer.
    Wu SG; Zhang WW; Liao XL; Sun JY; Li FY; Su JJ; He ZY
    Breast; 2017 Aug; 34():115-121. PubMed ID: 28577471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
    Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.